Company

Synthetic Design Lab

Synthetic Design Lab develops a platform to improve targeted delivery of antibody-drug conjugates for cancer treatment.

About

Synthetic Design Lab develops the SYNTHBODY platform to improve delivery of antibody-drug conjugates for cancer treatment. The company aims to advance its first therapies into clinical trials. Founded in 2025, it is based in San Francisco, US. In April 2025, it raised USD 20.00 mn in Seed funding from Godfrey Capital and Playground Ventures.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in